Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Antibiotics>Other antibiotic Drugs>Tunicamycin
Tunicamycin
  • Tunicamycin

Tunicamycin NEW

Price $65 $153 $273
Package 1mg 5mg 10mg
Min. Order:
Supply Ability: 10g
Update Time: 2024-11-19

Product Details

Product Name: Tunicamycin CAS No.: 11089-65-9
Purity: 98.77% Supply Ability: 10g
Release date: 2024/11/19

Product Introduction

Bioactivity

NameTunicamycin
DescriptionTunicamycin is a mixture of antibiotics that inhibit N-linked glycosylation by blocking GlcNAc phosphotransferase (GPT). Tunicamycin has antitumor activity, as well as anti-bacterial, anti-fungal, and anti-viral activity.
In vitroMETHODS: Human hepatocellular carcinoma cells Hep3B were treated with Tunicamycin (1 μg/mL), camptothecin (3 μM), etoposide (5 μM), taxol (0.1 μM), and vincristine (0.1 μM) for 48 h, and cell death was detected by Flow Cytometry. RESULTS: Tunicamycin significantly inhibited apoptosis induced by TOP inhibitors (camptothecin and etoposide) but not by microtubule-targeting drugs (taxol and vincristine). [1] METHODS: Human hepatocellular carcinoma cells PLC/PRF/5, MHCC-97L and MHCC-97H were treated with Tunicamycin (2.5 μg/mL) for 24 h, and the expression levels of the target proteins were detected by Western Blot. RESULTS: Tunicamycin inhibited the phosphorylation of Akt in the three hepatocellular carcinoma cell lines. [2]
In vivoMETHODS: To investigate the effects on hepatic energy metabolism, Tunicamycin (1 mg/kg) was administered intraperitoneally to C57BL/6 mice as a single injection. RESULTS: Tunicamycin significantly induced hepatic yellow coloration and endoplasmic reticulum stress, and increased serum aspartate aminotransferase and alanine aminotransferase levels.Tunicamycin altered hepatic energy homeostasis by increasing triglyceride accumulation and decreasing glycogen content. [3] METHODS: To test the antitumor activity in vivo, Tunicamycin (0.25 mg/kg) was administered orally twice a week for four weeks to Balb/c (nu/nu) mice harboring human triple-negative breast carcinoma tumor MDA-MB-231. RESULTS: Within one week of oral administration of Tunicamycin, MDA-MB-231 tumor xenografts were reduced by 65% and there was no systemic and/or organ failure. [4]
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility InformationDMSO : 14.37 mg/mL (20 mM), Sonication is recommended.
KeywordsN-linked | DNA | UDP-HexNAc | inhibit | anti-cancer | Inhibitor | ATF6 | synthesis | Tunicamycin | Influenza Virus | invasion | XBP-1 | Bacterial | Fungal | glycoprotein | Antibiotic
Inhibitors RelatedNeomycin sulfate | Dimethyl sulfoxide

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$153.00/5mg
VIP3Y
TargetMol Chemicals Inc.
2024-11-19
$1.00/1kg
VIP6Y
Hebei Weibang Biotechnology Co., Ltd
2024-11-11
$100.00/1KG
VIP5Y
Hebei Mojin Biotechnology Co., Ltd
2023-09-05
$15.00/1KG
Zhuozhou Wenxi import and Export Co., Ltd
2021-06-26
$9.80/1KG
VIP5Y
Career Henan Chemical Co
2020-02-06
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hills
INQUIRY